… to investigate clinical outcomes in 51 patients treated with ibrutinib carrying either a single …
initiation of ibrutinib for mutations in the TP53 gene (exons 2–10 +2 base-pair intronic overlap) …

… approach, association with clinical outcomes, and the uptake of family variant testing. … coding
exons, 10–20 base pairs of adjacent intronic sequencing on either side of the coding exons…

… Amplicon-based PCR-NGS of exons 14 to 15 detected FLT3-ITDs of at least 6 base pairs to
a … Interestingly, intermediate RFS and OS were observed for patients positive for either NPM1 …

… HLA-A and 2 mutations in cytoplasmic tail (exon 7) of HLA-C (… least 2 years before the clinical
diagnosis of clonal evolution … expand and become clinically evident, either by accumulating …

… encoding CMV-Cre-recombinase to delete exons 2–3 of Keap1 and exons 3–6 of Stk11 in
the … were only upregulated in clinical samples, suggesting they may either represent context-…

… All VGLL3 fusions were in-frame and involved exon 2, fused with either TCF12 exon 16,
EP300 exon 31, or PPARGC1A exon 5, respectively. This series characterizes a distinctive …

… Prior clinical studies have demonstrated HR+ breast cancers with mutations in either
exon 9 or exon 20 exhibited decreased response to ET (4). To address this clinically, several …

… generally poor prognosis and clinical outcome. Additionally, the … Mutations in exons 12 and
13 of the KRAS gene have not … Diagnosis of pancreatic carcinoma was routinely made either …

… DMD patients eligible for either exon-51, exon-53 or exon-45 skipping treatments account …
DMD patients are not eligible for either exon-51, exon-53, or exon-45 skipping therapies and …

… Clinical outcomes of NSCLC patients with rare EGFR mutations in exon 18 after EGFRi …
complex EGFR mutations that contained either exon 20 insertions or T790M mutations [79]. …